Value Proposition canvas- Customer needs and pains
Weekly equity-report by epic research 15 april 2013
1. WEEKLY NEWS
Infosys Q4 disappoints; downgrades loom on
weak guidance
Infosys shares plunged 21 percent to Friday close at a
near-four month low of Rs 2295.45, after its fourth
quarter numbers and FY14 guidance were way below
market expectations. This is the biggest single day fall
since April 10, 2003, when the stock tanked 26 percent
after missing its guidance.The IT major's fourth quarter
net profit rose slightly higher-than-expected 3 percent
year-on-year (1 percent quarter-on-quarter) to Rs 2,394
crore, helped by higher other income and lower income
tax expenses.
WEEKLY EQUITY
NEWSLETTER FinMin pitches for ratings upgrade for economy
TH
15 APRIL 2013 with Fitch
The Finance Ministry today made a strong case for
rating upgrade of Indian economy by global agency
Fitch on the back of increasing investments, declining
import of gold and government's commitment to fiscal
MARKET UPDATE:-
prudence.The issue of rating upgrade was raised by
Finance Ministry officials at a meeting with the
Nifty down by 25 pts and
settle at 5528.55 representatives of Fitch here. The meeting was
attended by Department of Economic Affairs Secretary
Bank Nifty up by 400 pts Arvind Mayaram, among others
at 11410.10
http://www.epicresearch.co 09752199966
09993959693
2. MARKET ANALYSIS
UNCERTAIN POLITICAL SITUATION IN INDIA AND SOME POOR MACRO NUMBERS IN THE RECENT PAST HAS
CAUSED THE INDIAN MARKETS TO UNDERPERFORM THE GLOBAL PEERS SINCE THE BEGINNING OF THE
CURRENT MONTH. RATHER THE FOREIGN INSTITUTIONAL INVESTORS (FII) WHICH TILL THE END OF THE
PREVIOUS MONTH WERE MOPPING UP INDIAN EQUITIES TURNED NET SELLERS IN THE EQUITY SEGMENT.
ON THE CONTRARY MOST OF THE GLOBAL MARKETS DURING THIS PERIOD RALLIED CONSIDERABLY. SO IT
APPEARS PERHAPS THAT THE INDIAN MARKET IS THE VICTIM OF PORTFOLIO REALIGNMENT BY THE GLOBAL
FUNDS IN FAVOR OF SAFER DEVELOPED ECONOMIES. ON THE OTHER HAND SOME OF THE MACRO
PARAMETERS HAVE BEEN DISAPPOINTING FOR SOME TIME AND PERHAPS THE INDIAN MARKET IS FINALLY
CATCHING UP TO MACRO REALITIES. ALL IN ALL THE MOOD APPEARS ABSOLUTELY BEARISH IN THE INDIAN
MARKETS AND THE DISAPPOINTING PROFITABILITY GUIDANCE GIVEN BY IT HEAVY WEIGHT INFOSYS FOR
FY14 AFTER DECLARING ITS Q4FY13 EARNINGS HAS ONLY ADDED FUEL TO THE FIRE. THE BENCHMARK
NIFTY TODAY FELL 65.45 POINTS TO CLOSE AT 5528.55 (MAINLY CONTRIBUTED BY INFOSYS BUTCHERING
WHICH FELL MORE THAN 21%). OVERALL FOR THE WEEK THE NIFTY FELL 24.70 POINTS.
THE NIFTY FUTURE PREMIUM OF THE APRIL SERIES NARROWED DOWN TO JUST 6.65 POINTS (5535.20) AS
COMPARED TO 16.05 POINTS ON MONDAY, PERHAPS AN INDICATION OF FRESH SHORTS BEING CREATED IN
THE NIFTY FUTURE SEGMENT. NOT JUST THE INDEX FUTURES, BUT SOME OF THE MAJOR STOCK FUTURES
SEGMENTS ALSO WITNESSED ADDITION OF OPEN INTEREST (OI) ON THE SHORT SIDE.
.
EXPERT OPINION
NIFTY WEEKLY PIVOTS
NIFTY BANK NIFTY
Nifty looks Bearish Bank Nifty looks Bearish
Strategy: Sell on rise Strategy: Sell on rise
Support:5450 Support: 11300
Resistance: 5600 Resistance: 11500
NIFTY WEEKLY PIVOTS
PIVOTS R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5937 5804 5671 5599 5538 5466 5406 5272 5139
http://www.epicresearch.co 09752199966
4. GAINERS AND LOOSERS
WEEKLY NIFTY GAINERS
SCRIPS RATE VOL. (000) PR. NET % CHANGE
CLOSE CHANGE
JP Associate 70.80 17933.75 64.10 6.70 10.45
Tata
275.15 8703.29 255.20 19.95 7.82
Motors
Ambuja
175.95 2616.38 164.75 11.20 6.80
Cement
Lupin 659.80 409.35 618.20 41.60 6.73
DLF 247.40 10156.85 232.80 14.60 6.27
. WEEKLY NIFTY LOOSERS
SCRIPS RATE VOL. PR. CLOSE NET % CHANGE
(000) CHANGE
Infosys 2296.65 546.62 2865.85 -569.2 -19.86
Tata Steel 299.5 3985.83 309.2 -9.7 -3.14
Coal India 299.9 2585.16 309.25 -9.35 -3.02
Jindal Steel 327.85 1631.55 335.55 -7.7 -2.29
Asian Paints 4662 73.49 4767.55 -105.55 -2.21
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.